Special Issues Policy

The Journal of Cancer Biomoleculars and Therapeutics (JCBT, eISSN: 3060-8856) occasionally publishes Special Issues to highlight emerging or focused topics in cancer biology, molecular medicine, and therapeutic development. These collections adhere to the same high standards as regular issues, with the following policies:

Proposal & Oversight
Special Issues are proposed by Editorial Board members or invited Guest Editors with domain expertise.
All proposals must include:
1. A clear topic rationale and scope.
2. Guest editor(s) names, affiliations, and CVs.
3. A proposed timeline (submission deadline, review period, etc.).
4. Final approval rests with the Editor-in-Chief (EIC) or designated Editorial Board members.

Peer Review & Ethical Standards
All submissions undergo the journal’s standard double-blind peer-review process, independent of Guest Editors.
Guest Editors may not handle manuscripts where conflicts of interest exist (e.g., authored by themselves, collaborators, or institutional colleagues).
The EIC reserves the right to reassign manuscripts or reject improperly reviewed submissions.

Guest Editor Responsibilities
Guest Editors must ensure diversity and inclusivity in submissions (no more than 25% of the issue’s content may originate from their own institutions).
They assist in identifying reviewers but do not make final editorial decisions.